Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study

  1. Lookup NU author(s)
  2. Professor Alan Boddy
  3. Dr Mark Verrill
  4. Julieann Sludden
  5. Kevin Fishwick
  6. Lynsey Robson
  7. Dr Jane Cassidy
  8. Professor Alan Calvert
Author(s)Boddy, A. V., Todd, R., Verrill, M., Sludden, J., Fishwick, K., Robson, L., Cassidy, J., Bisset, D., Garzone, P. D., Calvert, A. H.
Publication type Article
JournalEuropean Journal of Cancer
Year2002
Volume38
IssueSupplement 7
PagesS34 no. 98
ISSN (print)0959-8049
ISSN (electronic)1879-0852
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
URLhttp://dx.doi.org/10.1016/S0959-8049(02)80747-X
DOI10.1016/S0959-8049(02)80747-X
Actions    Link to this publication
Share